Disc Medicine, Inc. Earnings Per Share, Basic and Diluted
Disc Medicine, Inc. (IRON) reported Earnings Per Share, Basic and Diluted of -$0.35 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-06
- Disc Medicine, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.35.
- Disc Medicine, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.43.
- Disc Medicine, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.38.
- Disc Medicine, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.59.
- Disc Medicine, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.78.
- Disc Medicine, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.70.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.35 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | -$1.78 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$0.43 10-Q · filed 2021-11-15 | -$1.37 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$0.38 10-Q · filed 2021-08-12 | -$0.94 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$0.59 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 | -$2.70 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$0.65 10-Q · filed 2021-11-15 | -$1.77 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$0.44 10-Q · filed 2021-08-12 | -$1.11 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$0.67 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |